Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brilinta for Pediatric Hepatic Artery Thrombosis
NCT04946929Phase 3Unknown
- Sponsor
- Renji Hospital
- Start
- Jul 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in hepatic artery thrombosis (HAT), sponsored by Renji Hospital. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
hepatic artery thrombosis (HAT)
Beyond the preview
Go deeper on NCT04946929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04946929.